Pseudomembranous colitis related to valaciclovir: a clinical case
Keywords:
Clostridium difficile, colitis, diarrhea, pseudomembranous colitis and valaciclovirAbstract
Clostridium difficile is a microbiological agent essentially nosocomial. In the last few years there have been important changes in its
epidemiology. Nowadays Clostridium difficile associated disease is
considered one of the most reported nosocomial diseases. There
is also evidence of an increasing number of cases in the community, with data suggesting increasing pathogen’s aggressiveness.
Antibiotics play a crucial role in the disease physiopathology.
Clindamycin, cephalosporins and penicillins are the higher risk
antibiotics, nevertheless, any antimicrobial agent can facilitate a
Clostridium difficile infection.
Given the theme relevance, the authors present a clinical report
of a case of pseudomembranous colitis secondary to valaciclovir,
a rare association according to literature.
Downloads
References
Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis 2008 ;46 (1):S4-11.
Yassin SF, Young-Fadok TM, Zein NN, Pardi DS. Clostridium difficile-associated diarrhea and colitis. Mayo Clin Proc 2001;76(7):725-730.
Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis
;46 (1):S19-31. Review
Poutanen SM, Simor AE. Clostridium difficile - associated diarrhea in adults. CMAJ 2004;171(1):51-58.
Kelly CP, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med 2008;359(18):1932-1940. Review.
De Andrés S, Ferreiro D, Ibánez M, Ballesteros A, García B, Agud JL. Clostridium difficile colitis associated with valaciclovir. Pharm World Sci
;26(1):8-9.
Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008;46 (1):S12-18. Review.
Gerding DN, Muto CA, Owens RC Jr. Treatment of Clostridium difficile infection. Clin Infect Dis 2008;46 (1):S32-42. Review.
Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45(3):302-307.
McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994;271(24):1913-1918.
Mimidis K, Papadopoulos V, Margaritis V, Thomopoulos K, Gatopoulou A, Nikolopoulou V, Kartalis G. Predisposing factors and clinical symptoms in HIV-negative patients with Candida esophagitis: are they always present? Int J Clin Pract 2005;59(2):210-213.
Chocarro Martínez A, Galindo Tobal F, Ruiz-Irastorza G, González López A, Alvarez Navia F, Ochoa Sangrador C, Martín Arribas MI. Risk factors for esophageal candidiasis. Eur J Clin Microbiol Infect Dis 2000;19(2):96-100
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
